674 results on '"Tzartos, Socrates"'
Search Results
2. A miR-124-mediated post-transcriptional mechanism controlling the cell fate switch of astrocytes to induced neurons
3. Myasthenia Gravis
4. Neuronal nicotinic acetylcholine receptor antibodies in autoimmune central nervous system disorders
5. Functional Signature of LRP4 Antibodies in Myasthenia Gravis
6. A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression
7. Glial fibrillary acidic protein (GFAP)-antibody in children with focal seizures of undetermined cause
8. Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions
9. Deciphering anti-MOG IgG antibodies: Clinical and radiological spectrum, and comparison of antibody detection assays
10. Kelch-like Protein 11 (KLHL11) Antibodies in Children With Seizures of Undetermined Cause
11. Novel Cell-Based Assay for Alpha-3 Nicotinic Receptor Antibodies Detects Antibodies Exclusively in Autoimmune Autonomic Ganglionopathy
12. Myasthenia Gravis
13. PheWAS and cross-disorder analysis reveal genetic architecture, pleiotropic loci and phenotypic correlations across 11 autoimmune disorders
14. Absence of neuronal nicotinic acetylcholine receptor antibodies in sera and CSF from schizophrenia patients
15. Potential Role of Antibodies against Aquaporin-1 in Patients with Central Nervous System Demyelination
16. Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
17. A Comparison of Two Analytical Approaches for the Quantification of Neurofilament Light Chain, a Biomarker of Axonal Damage in Multiple Sclerosis
18. Myasthenia Gravis
19. Specific removal of autoantibodies by extracorporeal immunoadsorption ameliorates experimental autoimmune myasthenia gravis
20. Characterization of a reproducible rat EAMG model induced with various human acetylcholine receptor domains
21. Kelch-like Protein 11 (KLHL11) Antibodies in Children With Seizures of Undetermined Cause.
22. The role of carbohydrate component of recombinant α7 nicotinic acetylcholine receptor extracellular domain in its immunogenicity and functional effects of resulting antibodies
23. MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK
24. Crystal structure of a human neuronal nAChR extracellular domain in pentameric assembly : Ligand-bound α2 homopentamer
25. Myasthenia gravis
26. Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis
27. Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis
28. RETRACTED ARTICLE: Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms
29. Myasthenia Gravis
30. Expression of extracellular domains of muscle specific kinase (MuSK) and use as immunoadsorbents for the development of an antigen-specific therapy
31. Scale up and safety parameters of antigen specific immunoadsorption of human anti-acetylcholine receptor antibodies
32. Emerging Therapies for the Treatment of Autoimmune Myasthenia Gravis
33. Antibodies to aquaporins are frequent in patients with primary Sjögren’s syndrome
34. Corrigendum: Crystal structure of the monomeric extracellular domain of α9 nicotinic receptor subunit in complex with α-conotoxin RgIA: Molecular dynamics insights into RgIA binding to α9α10 nicotinic receptors
35. Plasma P-Tau181 for the Discrimination of Alzheimer’s Disease from Other Primary Dementing and/or Movement Disorders
36. Structural Insights into the Role of β3 nAChR Subunit in the Activation of Nicotinic Receptors
37. A Recombinant Acetylcholine Receptor α1 Subunit Extracellular Domain Is a Promising New Drug Candidate for Treatment Of Myasthenia Gravis
38. Expression of the Acetylcholine Receptor α-Subunit Gene is Associated with Paraneoplastic Myasthenia Gravis in Mixed Thymoma
39. Abnormal Thymocyte Development and Neurofilament-Reactive Thymocytes in Thymoma
40. Current Concepts on the Structure of Acetylcholine Receptor with Relevance to Myasthenia Gravis and Experimental Autoimmune Myasthenia Gravis Pathogenesis
41. Evidence for an Upregulation of Acetylcholine Receptor Messenger Subunits Triggered by Antibody-Mediated Receptor Internalization in Human Myasthenia Gravis Muscles
42. Low Levels of Acetylcholine Receptor Delta-Subunit Message and Protein in Human Thymus Suggests the Occurrence of ‘Triplet Receptors’ in Thymic Myoid Cells
43. Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine
44. Retraction Note to: Juvenile-onset myasthenia gravis: autoantibody status, clinical characteristics and genetic polymorphisms
45. Concordance of cerebrospinal fluid real‐time quaking‐induced conversion across the European Creutzfeldt–Jakob Disease Surveillance Network
46. IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies
47. Concordance of CSF RT-QuIC across the European Creutzfeldt-Jakob Disease surveillance network
48. Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis
49. Inflammation decreases the level of alpha7 nicotinic acetylcholine receptors in the brain mitochondria and makes them more susceptible to apoptosis induction
50. Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors — Recommendations for methods and experimental designs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.